GH Research (GHRS)
GH Research Statistics
Share Statistics
GH Research has 62.03M shares outstanding. The number of shares has increased by 19.22% in one year.
| Shares Outstanding | 62.03M |
| Shares Change (YoY) | 19.22% |
| Shares Change (QoQ) | 19.22% |
| Owned by Institutions (%) | 59% |
| Shares Floating | 40.44M |
| Failed to Deliver (FTD) Shares | 17 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.91M, so 3.67% of the outstanding shares have been sold short.
| Short Interest | 1.91M |
| Short % of Shares Out | 3.67% |
| Short % of Float | 6.27% |
| Short Ratio (days to cover) | 30.57 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -9.6. GH Research's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | -9.6 |
| PS Ratio | 0 |
| Forward PS | 3.1 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for GH Research.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.23, with a Debt / Equity ratio of 0.
| Current Ratio | 17.23 |
| Quick Ratio | 17.23 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-711.74K |
| Employee Count | 50 |
| Asset Turnover | null |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -17.83% in the last 52 weeks. The beta is 0.85, so GH Research's price volatility has been higher than the market average.
| Beta | 0.85 |
| 52-Week Price Change | -17.83% |
| 50-Day Moving Average | 11.81 |
| 200-Day Moving Average | 9.85 |
| Relative Strength Index (RSI) | 34.86 |
| Average Volume (20 Days) | 517.66K |
Income Statement
| Revenue | n/a |
| Gross Profit | -315K |
| Operating Income | -41.22M |
| Net Income | -35.59M |
| EBITDA | -41.15M |
| EBIT | -41.22M |
| Earnings Per Share (EPS) | -0.68 |
Balance Sheet
The company has 100.79M in cash and 624K in debt, giving a net cash position of 100.17M.
| Cash & Cash Equivalents | 100.79M |
| Total Debt | 624K |
| Net Cash | 100.17M |
| Retained Earnings | -106.45M |
| Total Assets | 188.27M |
| Working Capital | 145.27M |
Cash Flow
In the last 12 months, operating cash flow was -42.28M and capital expenditures -49K, giving a free cash flow of -42.33M.
| Operating Cash Flow | -42.28M |
| Capital Expenditures | -49K |
| Free Cash Flow | -42.33M |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GHRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for GHRS is $32, which is 252.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $32 |
| Price Target Difference | 252.4% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Scores
| Altman Z-Score | 35.27 |
| Piotroski F-Score | 2 |